Evidence map›Paper›PMID 26379655›Full record

ArticleFrontiers in microbiology2015

Histatin 5 inhibits adhesion of C. albicans to Reconstructed Human Oral Epithelium.

Eduardo B Moffa, Maria C M Mussi, Yizhi Xiao, Saulo S Garrido, Maria A A M Machado, Eunice T Giampaolo, Walter L Siqueira

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Metabolic modulation and multi-species interaction:Frontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Antimicrobial Peptides with Anti-International journal of molecular sciences · 2022
    Review
  11. Review
  12. Review
  13. Inhibition ofAntibiotics (Basel, Switzerland) · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Bioactive Peptides Against Fungal Biofilms.Frontiers in microbiology · 2019
    Review
  18. Article
  19. Article
  20. Frontiers in microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Eduardo B MoffaThe University of Western Ontario - Department of Biochemistry and Schulich Dentistry, Schulich School of Medicine and Dentistry, London, ON Canada ; Department of Dental Materials and Prosthodontics, Araraquara Dental School - Universidade Estadual Paulista, São Paulo Brazil.
Maria C M MussiThe University of Western Ontario - Department of Biochemistry and Schulich Dentistry, Schulich School of Medicine and Dentistry, London, ON Canada ; School of Dentistry, University of São Paulo, São Paulo Brazil.
Yizhi XiaoThe University of Western Ontario - Department of Biochemistry and Schulich Dentistry, Schulich School of Medicine and Dentistry, London, ON Canada.
Saulo S GarridoDepartment of Biochemistry and Technological Chemistry - Institute of Chemistry - Universidade Estadual Paulista, São Paulo Brazil.
Maria A A M MachadoDepartment of Pediatric Dentistry, Orthodontics and Public Health, Bauru Dental School, University of São Paulo, Bauru Brazil.
Eunice T GiampaoloDepartment of Dental Materials and Prosthodontics, Araraquara Dental School - Universidade Estadual Paulista, São Paulo Brazil.
Walter L SiqueiraThe University of Western Ontario - Department of Biochemistry and Schulich Dentistry, Schulich School of Medicine and Dentistry, London, ON Canada.
Universidade Estadual Paulista (Unesp) · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is the most pathogenic fungal species, commonly colonizing on human mucosal surfaces. As a polymorphic species, C. albicans is capable of switching between yeast and hyphal forms, causing an array of mucosal and disseminated infections with high mortality. While the yeast form is most commonly associated with systemic disease, the hyphae are more adept at adhering to and penetrating host tissue and are therefore frequently observed in mucosal fungal infections, most commonly oral candidiasis. The formation of a saliva-derived protein pellicle on the mucosa surface can provide protection against C. albicans on oral epithelial cells, and narrow information is available on the mucosal pellicle composition. Histatins are one of the most abundant salivary proteins and presents antifungal and antibacterial activities against many species of the oral microbiota, however, its presence has never been studied in oral mucosa pellicle. The objective of this study was to evaluate the potential of histatin 5 to protect the Human Oral Epithelium against C. albicans adhesion. Human Oral Epithelial Tissues (HOET) were incubated with PBS containing histatin 5 for 2 h, followed by incubation with C. albicans for 1 h at 37°C. The tissues were then washed several times in PBS, transferred to fresh RPMI and incubated for 16 h at 37°C at 5% CO2. HOET were then prepared for histopathological analysis using light microscopy. In addition, the TUNEL assay was employed to evaluate the apoptosis of epithelial cells using fluorescent microscopy. HOET pre-incubated with histatin 5 showed a lower rate of C. albicans growth and cell apoptosis when compared to the control groups (HOET alone and HOET incubated with C. albicans). The data suggest that the coating with histatin 5 is able to reduce C. albicans colonization on epithelial cell surfaces and also protect the basal cell layers from undergoing apoptosis.

Indexed as

Candida albicanshistatinsmucosal pellicleoral mucosasalivary proteins

Identifiers

PMID26379655
PMCPMC4551819
OpenAlexW1906380930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.